N2/3期下咽癌诱导化疗后转移性颈部淋巴结的处理
回顾性研究92例N2/3期下咽癌患者,按诱导化疗后反应分为三组:颈部淋巴结清扫后同步放化疗组(组1)、手术加术后放化疗组(组2)、原发灶及区域灶同步放化疗组(组3)。组1总生存和无病生存显著高于组2(p=0.038,p=0.031)和组3(均p=0.018),组1区域控制率显著高于组3(p=0.041)。结论认为对原发灶有反应但淋巴结无反应者,颈部淋巴结清扫后同步放化疗是最佳选择。
要点
- 组1总生存和无病生存显著高于组2(p=0.038,p=0.031)和组3(均p=0.018)。
- 组1区域控制率显著高于组3(p=0.041)。
- 组1与组2局部和区域控制无显著差异(p=0.746,p=0.302)。
核心结论
- 对原发灶有反应但颈部淋巴结无反应的患者,颈部淋巴结清扫后同步放化疗是最佳选择。
研究设计与样本
- 回顾性研究纳入92例N2/3期下咽癌患者,按诱导化疗后反应分为三组:组1为颈部淋巴结清扫后同步放化疗,组2为手术加术后放化疗,组3为原发灶及区域灶同步放化疗。
主要发现
- 组1总生存显著高于组2(p=0.038)和组3(p=0.018)。
- 组1无病生存显著高于组2(p=0.031)和组3(p=0.018)。
- 组1区域控制率显著高于组3(p=0.041)。
- 组1与组2局部控制无显著差异(p=0.746),区域控制无显著差异(p=0.302)。
临床怎么用
- 作者认为,对原发灶有反应但颈部淋巴结无反应的患者,颈部淋巴结清扫后同步放化疗是最佳选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: For patients with less chemosensitive neck nodes, poor prognosis after chemoradiotherapy (CRT) could be predicted and neck dissection is needed. METHODS: Ninety-two N2/3 hypopharyngeal carcinoma patients were retrospectively studied. According to response after induction chemotherapy (ICT), patients were treated with neck dissection followed by concurrent CRT (CCRT) (group 1), surgery plus postoperative CRT (group 2), or CCRT for primary and regional sites (group 3). RESULTS: Overall survival and disease-free survival rates of group 1 were significantly higher than group 2 (p = 0.038, p = 0.031) and group 3 (both p = 0.018). Regional control rate of group 1 was significantly higher than group 3 (p = 0.041). There were no significant differences between groups 1 and 2 regarding local and regional control (p = 0.746, p = 0.302). CONCLUSIONS: Neck dissection followed by CCRT is the best choice for patients with responsive primary but nonresponsive nodes.
引用
- Li F, Hsueh C, Gong H, et al. The management of metastatic neck nodes following induction chemotherapy in N2/3 classification hypopharyngeal carcinoma. Head Neck. 2022. PMID: 35915865. doi:10.1002/hed.27106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。